1. 1889 Prospective, non-randomised, open-label study of UDPgluconoryltransferase (UGT) 2B17 genotype as a predictive marker of exemestane pharmacokinetics (PK) in post-menopausal hormone receptor (HR)-positive Asian metastatic breast cancer (MBC) patients progressing after prior endocrine therapy. (September 2015) Authors: Wong, A.; Wang, L.Z.; Wong, F.C.; Ow, S.; Nesaretnam, K.; Pang, A.; Tan, C.S.; Lim, Y.W.; Ho, G.F.; Lee, Y.; Yap, H.L.; Phang, S.; Alip, A.B.; Seng, K.Y.; Tai, B.C.; Walsh, R.; Goh, B.C.; Lee, S.C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗